ICAM1 and neoplasm: After exposure to β− particle emission using Sm-153, a bone-seeking radionuclide used to palliate metastatic bone pain, different human tumor cell lines demonstrated upregulation of at least two of the following markers: Fas, MHC-1, ICAM-1, CEA, and MUC-1 [133].